市场调查报告书
商品编码
1463697
北美眼底相机市场预测至 2030 年 - 区域分析 - 按类型、便携性、应用和最终用户North America Fundus Cameras Market Forecast to 2030 - Regional Analysis - by Type, Portability, Application, and End User |
2022年北美眼底相机市值为2.6126亿美元,预计2030年将达到4.8943亿美元;预计2022年至2030年CAGR为8.2%。
糖尿病视网膜病变筛检程序的增加推动了北美眼底相机市场
糖尿病患者常出现眼科疾病,如角膜异常、青光眼、白内障和神经病变。糖尿病视网膜病变是与该疾病相关的最常见且可能致盲的併发症。这种併发症是美国 25-74 岁族群失明的主要原因。根据 Medscape 报告,美国约有 70 万人患有增殖性糖尿病视网膜病变,年发生率为 65,000 例。此外,美国40岁以上人口中糖尿病视网膜病变的盛行率高达28.5%。因此,美国人口中糖尿病视网膜病变盛行率的上升加速了对安全、有效和高效的诊断系统(例如眼底照相机)的需求。眼底照相机单元可以是固定的或可携式的。与眼科诊所配备的桌上型设备相比,包括手持式摄影机在内的便携式设备以低成本和简化的操作彻底改变了糖尿病视网膜病变筛检计画。然而,桌上型眼底相机可提供良好的影像品质。
北美眼底相机市场概况
眼底摄影有助于检测和筛检可治疗和可预防的失明的各种原因,特别是 DR、老年黄斑部病变、青光眼和早产儿视网膜病变。根据疾病管制与预防中心的数据,老年性黄斑部病变 (AMD) 是 65 岁及以上美国人失明和视力丧失的主要原因。据 CDC 称,预计到 2050 年,美国老年人口将从 2015 年的 4800 万增加到 8800 万,几乎翻一番。 DR 是糖尿病患者常见的复杂情况。根据国际糖尿病联盟 (IDF) 的数据,2021 年约有 5.37 亿成年人(20-79 岁)患有糖尿病。美国小儿眼科和斜视协会(AAPOS) 的研究(于2023 年4 月更新)分析称,在美国,每年约有390 万婴儿出生时患有早产儿视网膜病变。此外,据估计,其中约有 14,000 人受到这种情况的影响,其中 90% 的人仅患有轻度疾病,近 1,100-1,500 人病情严重,需要接受治疗。因此,人口中早产儿视网膜病变、DR和老年黄斑部病变的盛行率上升有助于美国眼底相机市场的成长。
北美眼底相机市场营收及 2030 年预测(百万美元)
北美眼底相机市场区隔
北美眼底相机市场根据类型、便携性、应用、最终用户和国家进行细分。
根据类型,北美眼底相机市场分为散瞳眼底相机、免散瞳眼底相机、混合眼底相机和ROP眼底相机。免散瞳眼底相机细分市场在 2022 年占据最大市场。
基于便携性,北美眼底相机市场分为手持式和桌上型。 2022 年,桌面细分市场占据了更大的市场。
根据应用,北美眼底相机市场分为糖尿病性视网膜病变、老年黄斑部病变、视网膜血管疾病等。 2022 年,糖尿病视网膜病变细分市场占最大市场。
根据最终用户,北美眼底相机市场分为医院、眼科中心等。 2022 年,医院细分市场占据最大市场份额。
按国家/地区划分,北美眼底相机市场分为美国、加拿大和墨西哥。 2022年,美国在北美眼底相机市场占有率中占据主导地位。
Nikon Corp、Topcon Corp、NIDEK CO LTD、Canon Inc、Carl Zeiss AG、Visionix USA Inc、Kowa Co Ltd 和 Volk Optical Inc 是北美眼底相机市场的一些领先厂商。
表中的内容
The North America fundus cameras market was valued at US$ 261.26 million in 2022 and is expected to reach US$ 489.43 million by 2030; it is estimated to grow at a CAGR of 8.2% from 2022 to 2030.
Increase in Diabetic Retinopathy Screening Procedures Fuel the North America Fundus Cameras Market
Patients who have diabetes often develop ophthalmic conditions such as corneal abnormalities, glaucoma, cataracts, and neuropathies. Diabetic retinopathy has been the most common and potentially blinding complication associated with the disease. This complication is a leading cause of blindness among persons aged 25-74 years in the US. As per the Medscape report, ~700,000 persons in the US suffer from proliferative diabetic retinopathy with an annual incidence of 65,000. Moreover, the prevalence of diabetic retinopathy in the US accounts for 28.5% among people aged 40 or older. Thus, the rising prevalence of diabetic retinopathy among the US population accelerates demand for safe, effective, and efficient diagnostic systems, such as fundus cameras. The fundus camera units can be fixed or portable. Portable units, including handheld cameras, have revolutionized diabetic retinopathy screening programs with low costs and simplified operations, compare to desktop ones equipped in ophthalmology clinics. However, desktop fundus cameras provide good image quality.
North America Fundus Cameras Market Overview
Fundus photography is instrumental in the detection and screening of various causes of treatable and preventable blindness, notably DR, age-related macular degeneration, glaucoma, and retinopathy of prematurity. According to the Centers for Disease Control and Prevention, age-related macular degeneration (AMD) is a leading cause of blindness and vision loss among Americans aged 65 and more. According to CDC, the geriatric population in the US is anticipated to nearly double from 48 million in 2015 to 88 million in 2050. Nearly 20 million adults in the US face some form of age-related macular degeneration. DR is a commonly seen complexity in diabetic patients. According to the International Diabetes Federation (IDF), ~537 million adults (20-79 years of age) were living with diabetes in 2021. The same source also reported that the total number of people living with diabetes is estimated to rise to 643 million by 2030. Further, the study (updated in April 2023) by the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) analyzed that annually in the US, ~3.9 million infants are born with retinopathy of prematurity. Moreover, ~14,000 of these are estimated to be affected by this condition and 90% of those affected have only mild disease, and nearly 1,100- 1,500 develop disease severe enough to require medical treatment. Therefore, such a rise in the prevalence of retinopathy of prematurity, DR, and age-related macular degeneration in the population contributes to the US fundus camera market growth in the US.
North America Fundus Cameras Market Revenue and Forecast to 2030 (US$ Million)
North America Fundus Cameras Market Segmentation
The North America fundus cameras market is segmented based on type, portability, application, end user, and country.
Based on type, the North America fundus cameras market is segmented into mydriatic fundus camera, non-mydriatic fundus camera, hybrid fundus camera, and ROP fundus camera. The non-mydriatic fundus camera segment held the largest market share in 2022.
Based on portability, the North America fundus cameras market is bifurcated into handheld and tabletop. The tabletop segment held a larger market share in 2022.
Based on application, the North America fundus cameras market is segmented into diabetic retinopathy, age-related macular degeneration, retinal vascular disorders, and others. The diabetic retinopathy segment held the largest market share in 2022.
Based on end user, the North America fundus cameras market is segmented into hospitals, ophthalmology centers, and others. The hospitals segment held the largest market share in 2022.
Based on country, the North America fundus cameras market is segmented into the US, Canada, and Mexico. The US dominated the North America fundus cameras market share in 2022.
Nikon Corp, Topcon Corp, NIDEK CO LTD, Canon Inc, Carl Zeiss AG, Visionix USA Inc, Kowa Co Ltd, and Volk Optical Inc are some of the leading players operating in the North America fundus cameras market.
Table of Content